The estimated Net Worth of James T Flynn is at least $457 millier dollars as of 1 October 2009. James Flynn owns over 9,000 units of BlackRock Health Sciences Trust stock worth over $210,850 and over the last 17 years James sold BME stock worth over $245,978.
Sign up
James Flynn BME stock SEC Form 4 insiders trading
James has made over 6 trades of the BlackRock Health Sciences Trust stock since 2009, according to the Form 4 filled with the SEC. Most recently James sold 9,000 units of BME stock worth $63,180 on 11 March 2015.
The largest trade James's ever made was selling 14,113 units of BlackRock Health Sciences Trust stock on 11 February 2015 worth over $114,598. On average, James trades about 278 units every 11 days since 2008. As of 1 October 2009 James still owns at least 5,000 units of BlackRock Health Sciences Trust stock.
You can see the complete history of James Flynn stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at BlackRock Health Sciences Trust
Over the last 20 years, insiders at BlackRock Health Sciences Trust have traded over $27,424 worth of BlackRock Health Sciences Trust stock and bought 5,012 units worth $181,509 . The most active insiders traders include Ralph Schlosstein, Jerrold B Harris et Karen P Robards. On average, BlackRock Health Sciences Trust executives and independent directors trade stock every 203 days with the average trade being worth of $147,131. The most recent stock trade was executed by Kyle Mc Clements on 31 January 2024, trading 625 units of BME stock currently worth $26,356.
What does BlackRock Health Sciences Trust do?
blackrock's business is investing on behalf of our clients, from large institutions to parents and grandparents, doctors and teachers who entrust their savings to us. we work only for our clients—period. our promise is to offer them the clearest thinking about what to do with their money and the products and services they need to secure a better financial future. that's why investors of all kinds have made us the world’s largest asset manager, entrusting us with trillions of dollars, and it’s why companies, institutions and global governments come to us for help meeting their biggest financial challenges. important disclosures: http://www.blackrock.com/corporate/en-us/compliance/social-media-guidelines
What does BlackRock Health Sciences Trust's logo look like?
Complete history of James Flynn stock trades at Blackrock & Resources Trust, BlackRock Floating Rate Income Trust, BlackRock Enhanced International Dividend Trust, BlackRock Enhanced Global Dividend Trust, BlackRock Credit Allocation Income Trust, BlackRock Enhanced Equity Dividend Trust et BlackRock Health Sciences Trust
BlackRock Health Sciences Trust executives and stock owners
BlackRock Health Sciences Trust executives and other stock owners filed with the SEC include:
-
Dr. Erin Xie Ph.D.,
Portfolio Mang. -
Thomas P. Callan C.F.A.,
Portfolio Mang. -
Dr. Xiang Liu Ph.D.,
Portfolio Mang. -
Jeffrey Gene Lee,
Portfolio Mang. -
Christopher M. Accettella,
Portfolio Mang. -
Dr. Erin Xie,
Portfolio Mang. -
Kyle G. McClements CFA,
Portfolio Mang. -
Thomas P. Callan C.F.A., CFA,
Portfolio Mang. -
Charles Choon Sik Park,
Chief Compliance Officer and Anti-Money Laundering Officer -
Xiang Liu,
-
Jerrold B Harris,
Director -
Richard Cavanagh,
Director -
Robert Glenn Hubbard,
Director -
Christopher Accettella,
-
Michael J Castellano,
Director -
Catherine A. Lynch,
Director -
Karen P Robards,
Director -
Kyle Mc Clements,
-
H Erin Xie,
-
W Carl Kester,
Director -
James Laforce,
Director -
Walter F Mondale,
Director -
Ralph Schlosstein,
Director -
Frank Fabozzi,
Director -
Kathleen F Feldstein,
Director -
James T Flynn,
Director -
George Nicholas Iii Beckwith,
Director -
Robert Kapito,
President & CEO of the Trust -
Henry Gabbay,
Director -
Dick Davis,
Director -
Kent Dixon,
Director -
Cynthia Egan,
Director -
Jeffrey Gene Lee,